DISPOSABLE BIOPSY FORCEPS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Disposable Biopsy Forceps Market Size and Forecast – 2025 to 2032

The Global Disposable Biopsy Forceps Market is estimated to be valued at USD 1.72 Bn in 2025 and is expected to reach USD 2.91 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032. This steady growth highlights increasing adoption of disposable biopsy forceps driven by rising prevalence of chronic diseases, advancements in minimally invasive surgery, and a growing preference for disposable medical instruments to reduce infection risks.

Key Takeaways of the Global Disposable Biopsy Forceps Market

• In 2025, standard disposable biopsy forceps lead the market with an estimated 45.2% of the market share.
• The oval cup segment is expected to contribute 24.4% of the market share in 2025.
• Additionally, with locking handle is projected to dominate with 65.4% share in 2025.
• North America is expected to lead the market, holding a share of 37.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 24.3% in 2025.

Market Overview

A key trend shaping the market is the innovation in material technology, leading to more durable and flexible disposable biopsy forceps that enhance precision and patient comfort. Additionally, the rising demand for outpatient diagnostic procedures and expanding healthcare infrastructure in emerging economies are propelling the market expansion. Furthermore, increasing awareness among healthcare professionals about infection control is encouraging the switch from reusable to disposable biopsy forceps, solidifying the market’s upward trajectory.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Disposable Biopsy Forceps Market Insights, By Product Type - Standard disposable biopsy forceps contribute the highest market share owing to their versatility and widespread clinical applicability

Standard disposable biopsy forceps account for the largest segment, holding an estimated 45.2% of the market share in 2025, as they are designed to deliver consistent and reliable tissue samples across diverse medical procedures. Their straightforward design ensures ease of use by healthcare professionals, reducing both procedural time and patient discomfort. Additionally, the disposable nature aligns with stringent infection control protocols, particularly in the context of rising awareness around hospital-acquired infections and cross-contamination risks.

For example, Jiangsu Grit Medical Technology Co., Ltd, a China-based manufacturer of endoscopic and surgical instruments, highlighted its disposable endoscopic biopsy forceps designed for tissue sampling in digestive and respiratory tracts. The products feature sharp jaws for precise sampling, coated designs to protect endoscope channels, and laser-welded components for durability, with multiple options in size and jaw type to meet clinical needs.

Disposable Biopsy Forceps Market Insights, By Jaw Type - Oval cup biopsy forceps command the highest market share, primarily due to their optimal balance of tissue acquisition efficiency and procedural safety

Oval cup is projected to hold the highest market share, accounting for 24.4% in 2025, where the cup has a sharp cutting edge that can help precisely excise the mucosa with minimum trauma to adjacent tissues, which is essential in a diagnostic process that demands a good quality sample of the mucosa in the histopathology laboratory. Moreover, oval cup forceps are useful in gastrointestinal and pulmonary endoscopic biopsies, which comprise a major part of the biopsy processes in the world. The design minimizes the risk of specimen fragmentation or crushing which is a frequent problem with other jaw designs such as alligator or serrated cups.

The improved sample integrity favors improved clinical outcomes by increasing the diagnostic accuracy. Also, oval cup forceps are likely to be easier to maneuver and control during navigation of such limited anatomical spaces, thus reducing the risks of the procedure. The high application of less invasive diagnostic methods in healthcare institutions increases the need of such designs.

Disposable Biopsy Forceps Market Insights, By Handle Type - Biopsy forceps equipped with locking handles dominate the market driven by their superior control and enhanced procedural precision

The with locking handle segment is anticipated to lead with a 65.4% share in 2025, as it allows clinicians to maintain a secure grip on tissue samples and reduces the risk of unintentional release during withdrawal. This aspect is especially important in processes where preservation of tissue integrity between pickup and removal is important in the success of the diagnostic process. Locking handles also help minimize procedure fatigue as the operator can have a consistent grip without constant exertion, enhancing ergonomics during lengthy or complicated procedures.

Such operational benefits are in great demand in areas of operation like gastroenterology and pulmonology where the biopsy methods demand careful manipulation of inner body tissues. Also, an added locked grip reduces the chances of sample loss in the line of work and, therefore, reduces the number of repeated procedures and the patient discomfort.

Regional Insights

To learn more about this report, Download Free Sample

North America Disposable Biopsy Forceps Market

Well-established health care infrastructure, use of advanced medical technology, and strong research and development activities are the main factors that drive North America’s dominance in the global disposable biopsy forceps market, with a projected share of 37.3% in in 2025. The region enjoys large government funding and conducive regulatory frameworks which promote innovation and ease the process of approval of medical devices. The U.S. in specific has a robust ecosystem, including major producers of medical devices, and many specialty healthcare providers.

As an example, CONMED Corporation, which is a medical technology company based in the U.S., focused on its Precisor and OptiBite Disposable Biopsy Forceps range that is specifically designed to be used in gastrointestinal and pulmonary procedures. The Precisor Hot model operates on the CAM design technology with precise cutting and high sample capacity with a Channel-Guard sheath which reduces the channel wear whereas the Precisor EXL model cuts clean instead of tearing.

Asia Pacific Disposable Biopsy Forceps Market

The Asia Pacific region is projected to drive the disposable biopsy forceps market growth at the fastest rate of 24.3% in 2025 due to the increasing number of healthcare facilities, the rising prevalence of chronic illnesses, as well as the growing geriatric populations. Government initiatives to improve healthcare accessibility, coupled with the rapid expansion of privatized healthcare centers, have significantly boosted market growth, particularly in countries such as China and India. Moreover, rising medical tourism and multinational corporations to localize manufacturing, bring a good balance of trade and economies of cost to this region.

As an illustration, CITEC, a Chinese company that manufactures endoscopy accessories, advertised its CITEC Disposable Biopsy Forceps to access through the endoscope biopsy ports to safely sample the tissue and at the same time avoid any leakage caused by loss of insufflation. The forceps will have sharp oval shaped cups, alligator jaws that prevent slipping and clean cutting edges that minimize bleeding. The devices have color-coded sheaths, length markers to facilitate accurate positioning, and rotatable handle options, which are offered in various sizes to use in bronchoscopy, gastroscopy, and enteroscopy procedures.

Disposable Biopsy Forceps Market Outlook for Key Countries

U.S. Disposable Biopsy Forceps Market Trends

The U.S. disposable biopsy forceps market is leading in the adoption of disposable biopsy forceps due to its developed healthcare system and healthcare centered policies. The U.S. FDA has strict regulatory requirements that make the product of high quality, and manufacturers are making innovations and introducing advanced tools in the market. Major competitors such as Boston Scientific and Medtronic are lending stress to the differentiation of their products, which lays emphasis on ease of use and greater precision. The focus on less invasive diagnostics in the country further increases the need to use disposable equipment to minimize the chances of infection during the procedure.

"For example, Cook Medical, a U.S.-based medical device company, highlighted its Captura Disposable Bronchoscope Biopsy Forceps, designed for collecting tissue samples from the bronchi and lungs. The single-use forceps come in different catheter lengths and cup designs such as fenestrated ones, and are designed to offer dependable service in the operating room during pulmonary procedures and safety and efficiency in the diagnostic sample.

Germany Disposable Biopsy Forceps Market Trends

The market in Germany is also advanced by the high production of medical devices and an extensive healthcare system which contributes to the high usage of new biopsy tools that boosts the market of disposable biopsy forceps. Government policies supporting healthcare technology and reimbursement are further driving market growth. In addition, companies such as B. Braun Melsungen AG are making significant investments in research and development to introduce advanced disposable biopsy forceps tailored for specific endoscopic procedures. Overall, the market reflects a balance between strong domestic manufacturing capabilities and robust export activities

For example, Micro-Tech Endoscopy, a worldwide manufacturer of endoscopic accessories, exhibited its Tru Bite Disposable Biopsy Forceps which enables safe and efficient tissue sample by its 32 styles of jaw, with or without spike, coated or not, oval shaped and alligator shaped. The TruBite is designed with high quality riveted joints, protective micro-cap to allow easy identification, and a working channel-friendly design that guarantees diagnostically conclusive biopsies with comfort and accuracy in the pediatric, gastric and colonoscopy procedures.

China Disposable Biopsy Forceps Market Trends

China’s market is rapidly expanding and forms a cornerstone of the global disposable biopsy forceps industry, supported by extensive healthcare reforms aimed at extending medical services to both urban and rural populations. Government efforts to modernize hospitals and invest in advanced medical device infrastructure further encourage adoption. Additionally, partnerships between local manufacturers and multinational companies such as Olympus and Merit Medical enhance distribution networks and improve cost-efficiency. Rising cancer incidence and the growing prevalence of chronic diseases are also driving an increase in diagnostic biopsies, which in turn fuels demand for single-use biopsy forceps.

For example, HonyMed, a China-based manufacturer of surgical instruments, represented its Disposable Biopsy Forceps capable of performing efficient tissue sampling during the process of endoscopy. The forceps comes in various diameters and length sizes, a broad selection of jaw type, a 360 degree handle, and a medical PE sheath that lessens friction and safeguards endoscopes. The single-use sterile forceps features spiked and coated models which guarantee accurate sampling, insertion, and consistency in terms of performance at an affordable price.

India Disposable Biopsy Forceps Market Trends

The growth of the Indian market of disposable biopsy forceps can be attributed to the improvement of medical infrastructure and to the rising awareness about preventive diagnostics. The opportunities are broadened by the emergence of the practice of private healthcare providers on the one hand, and the attempts of the government to enhance diagnostic services on the other hand. Cost-insensitive healthcare providers prefer disposable biopsy equipment that minimizes infection risk while maintaining high diagnostic quality

For example, the Radial Jaw 4 Single-Use Jumbo Bio Paspsy Forceps is manufactured by Boston Scientific among other Biopsy forceps lines. Its forceps fit bigger tissue samples, which have better sample yield and handling.

End User Feedback and Unmet Needs - Disposable Biopsy Forceps Market

• End users of disposable biopsy forceps, particularly clinicians in hospitals, specialty clinics, and ambulatory surgical centers, consistently emphasize the value of single-use instruments for infection control and procedural efficiency. Many gastroenterologists highlight the convenience of pre-sterilized devices that eliminate the need for reprocessing and reduce turnaround time between procedures. A positive example comes from large endoscopy units in North America, where physicians report that advanced jaw designs in certain models enable cleaner cuts and larger, diagnostically conclusive samples. This has translated into greater diagnostic confidence and fewer repeat biopsies, improving workflow efficiency and patient experience. Such feedback reflects the importance of precision engineering and design reliability, which directly influence adoption rates across high-volume centers.
• At the same time, end users often raise concerns around recurring issues such as high costs, environmental waste from single-use products, and limited availability of forceps optimized for specialized patient groups like pediatrics or those with complex anatomies. For instance, smaller regional hospitals in developing markets frequently report budget constraints that make premium disposable forceps unaffordable, forcing them to rely on reusable instruments despite infection control risks. These concerns highlight unmet needs around affordability, eco-friendly alternatives, and broader product customization. Addressing these areas could unlock opportunities for manufacturers to expand in cost-sensitive regions, build loyalty through sustainable solutions, and inspire innovation in design versatility. Policymakers and industry stakeholders who respond proactively to these gaps can not only strengthen market growth but also improve healthcare outcomes by ensuring safe, effective, and accessible biopsy tools for diverse patient populations.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In April 2025 Medtronic plc, a global healthcare technology leader, announced a strategic distribution agreement with Dragonfly Endoscopy, a company focused on advancing pancreaticobiliary procedures, to introduce the Dragonfly system in the U.S. market. The new platform is designed to enhance pancreaticobiliary endoscopy by improving visualization, maneuverability, and therapeutic capabilities, enabling larger biopsy samples and more effective stone clearance, marking a significant step forward in patient care and procedural innovation.
• In November 2022, the World Health Organization partnered with Anambra State to launch a cervical cancer screening and treatment project aimed at women of reproductive age across the state. The initiative, aligned with International Cancer Week’s theme of bridging the cancer care gap, includes donations of medical equipment such as punch biopsy forceps, training for 100 health workers, and support for four hospitals and seven primary health centers.

Top Strategies Followed by Global Disposable Biopsy Forceps Market Players

• Most of the established market leaders tend to concentrate on heavy investment in research and development (R&D) to fuel innovation and to produce high-performance and reliable products of high medical standards. These companies are aware of the importance of constant innovation to their competitive edge and as such they have come up with biopsy forceps that are more precise and long lasting with easy-to-use designs. Simultaneously, they have been actively establishing strategic agreements and alliances with key industry players, such as original equipment manufacturer (OEMs), health care providers, and technology companies.
  • As an example, STERIS Corporation, an international provider of infection prevention and surgical solutions, highlighted its Centra Disposable Biopsy Forceps intended to be used in gastrointestinal endoscopy. The single use device has a variety of jaw configurations including or without a needle and serrated or plain cups and has different catheter markers to know when to insert the device. The Centra forceps has a swiveling jaw design with a wide 90-degree opening that allows the pivoting of the forceps and the accurate sampling of the tissue to allow accurate pathology analysis.

• The Middle-tier players in the disposable biopsy forceps market follow a somewhat different strategy, focusing on delivering effective yet cost-efficient solutions. Their core approach emphasizes balancing quality with affordability to serve price-conscious customers, particularly smaller hospitals and clinics in both developed and developing regions. By offering mid-range products that maintain reliable performance without significantly compromising on features, these players are able to attract a broad customer base seeking value for money.
  • For example, the India-based manufacturer, Medorah Meditek, declared the introduction of its MEDORAH Pediatric Biopsy Forceps, a one-time sterile instrument made of the medical grade stainless steel. This was a specifically crafted product to be used in the precision sampling of pediatric patients, with an ultra-fine grasping mechanism that provides a secure tissue collection of hard-to-reach areas that cause minimum trauma.

• One of the common strategies that small-scale players in the disposable biopsy forceps market use to remain in the market despite the high competition is the niche approach that focuses on specialization and innovation. They do not have to compete directly with the giants in the industry on a volume basis, but focus on the creation of special features or technologically embedded solutions that could resolve certain clinical needs or operational issues.
  • For example, Argon Medical Devices provides its Jawz Endomyocardial Biopsy Forceps, a single-use instrument designed to perform cardiac tissue biopsy that can be customized to fit in different curvatures and coated versions to achieve accuracy and safety in heart operations. Likewise, INRAD, Inc. focuses on the area of innovation in biopsy equipment with products like the PreciseCore “no-throw” system and SelectCore variable-throw needles that are aimed to minimize the risks of working in the delicate equipment sphere and offer more control to a physician.

Market Report Scope

Disposable Biopsy Forceps Market Report Coverage

Disposable Biopsy Forceps Market Dynamics

To learn more about this report, Download Free Sample

Disposable Biopsy Forceps Market Driver - Rising Prevalence of Cancer and Gastrointestinal Diseases

The increasing incidence of cancer and gastrointestinal disorders worldwide serves as a significant driver for the disposable biopsy forceps market. As the number of patients diagnosed with conditions such as colorectal cancer, gastric cancer, and other GI tract abnormalities continues to grow, the demand for accurate diagnostic tools, including biopsy forceps, escalates accordingly. Disposable biopsy forceps offer distinct advantages in preventing cross-contamination and infection, which is especially critical in immunocompromised cancer patients undergoing frequent endoscopic procedures. Moreover, the advancements in minimally invasive diagnostic techniques have made biopsies a routine part of early detection and monitoring of gastrointestinal diseases, further propelling the need for reliable and sterile biopsy instruments.

For example, in February 2025, the World Health Organization reported that cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or one in six deaths. The most common cancers were breast, lung, colon and rectum, prostate, skin, and stomach, with lung cancer leading as the top cause of cancer deaths. Risk factors such as tobacco use, obesity, alcohol, poor diet, physical inactivity, and air pollution continue to drive a significant share of cases, while infections like HPV and hepatitis account for nearly a third of cancers in low- and lower-middle-income countries. Moreover, in July 2025, Dana-Farber Cancer Institute reported that gastrointestinal cancers such as colorectal, pancreatic, esophageal, and stomach cancers are rising sharply among people under 50.

Disposable Biopsy Forceps Market Opportunity - Increasing Adoption of Robot-Assisted Endoscopic Procedures

The global disposable biopsy forceps market stands to benefit significantly from the rising adoption of robot-assisted endoscopic procedures in healthcare. Robot-assisted technologies are revolutionizing minimally invasive surgeries by enhancing precision, flexibility, and control during endoscopic interventions. As these advanced robotic systems become more prevalent in hospitals and specialty clinics worldwide, the demand for compatible, high-quality disposable biopsy forceps is expected to surge. These robotic platforms require specialized instruments that ensure compatibility with robotic arms and deliver consistent performance to minimize procedure time and patient risk. Disposable biopsy forceps, by offering sterile, single-use advantages, align seamlessly with the infection control protocols integral to robotic surgeries.

For example, Intuitive Surgical, a global leader in robotic-assisted surgery, introduced its new da Vinci 5 system with more than 150 design upgrades and advanced features such as force feedback, improved 3D vision, and streamlined workflows aimed at enhancing minimally invasive procedures. The company also highlighted its integration with My Intuitive+ digital tools for real-time collaboration and training, while continuing to expand its endoscopic instrument line including disposable biopsy forceps to support safer and more precise tissue sampling in diagnostic and surgical care.

Analyst Opinion (Expert Opinion)

• The disposable biopsy forceps market is gaining momentum as hospitals and specialty centers increasingly adopt single-use devices to reduce cross-contamination risks and improve patient safety. Growth is being fueled by technological advancements in jaw design and coatings that allow for more precise and less traumatic tissue sampling. Rising awareness of early cancer detection, coupled with regulatory encouragement for infection prevention, is further supporting uptake. At the same time, the market faces challenges such as the environmental impact of single-use devices and cost pressures in resource-limited settings. Yet, opportunities remain strong with innovations in eco-friendly materials and expanding access to endoscopic procedures in emerging markets. Industry gatherings like Digestive Disease Week in the U.S., UEG Week in Europe, and APDW in Asia Pacific have, over the past few years, provided vital platforms for researchers, manufacturers, and clinicians to share updates on biopsy technologies, shaping both practice and policy around minimally invasive diagnostics.
• Recent initiatives also underscore the sector’s progress. Companies like Medtronic and Cook Medical have expanded their endoscopy portfolios with advanced disposable biopsy forceps, reflecting a focus on safety and performance. Meanwhile, collaborations such as WHO’s support for cancer screening projects in Nigeria, which involved the donation of biopsy equipment to public health centers, show how global health bodies are pushing access to diagnostic tools in underserved regions. These examples, along with pilot programs across Europe and Asia Pacific to strengthen cancer screening infrastructure, are setting the stage for greater adoption and wider integration of disposable biopsy forceps into routine clinical workflows worldwide.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Standard Disposable Biopsy Forceps
  • Jumbo Disposable Biopsy Forceps
  • Hot Disposable Biopsy Forceps
  • Radial Jaw Disposable Biopsy Forceps
• Jaw Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Oval Cup
  • Serrated Cup
  • Alligator Cup
  • Needle Cup
• Handle Type Insights (Revenue, USD Bn, 2020 - 2032)
  • With Locking Handle
  • Without Locking Handle
• Coating Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Coated Forceps
  • Uncoated Forceps
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Gastrointestinal Endoscopy
  • Bronchoscopy and Pulmonology (Lungs and Airways)
  • Laparoscopy (Abdominal and Pelvic Organs)
  • Urology Endoscopy (Bladder, Urethra, Kidneys)
  • Hysteroscopy and Gynecology (Uterus and Cervix)
  • Arthroscopy (Joints)
  • ENT (Ear, Nose, Throat) Endoscopy
  • Other Applications (e.g., Neuroendoscopy)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Diagnostic Centers
  • Others (Academic and Research Institutes)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Olympus Corporation
  • Boston Scientific
  • Cook Medical
  • KARL STORZ
  • HOYA (Pentax Medical)
  • Argon Medical
  • CONMED Corporation
  • Cardinal Health
  • Braun SE
  • Micro-Tech Endoscopy
  • Bioags
  • Jiuhong
  • Anrui
  • Fujifilm
  • Stryker

Sources

Primary Research Interviews

Industry Stakeholders List

• Senior R&D Managers in Endoscopy Device Companies
• Hospital Procurement Officers

End Users List

• Gastroenterologists
• Pulmonologists

Government and International Databases

• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• World Health Organization (WHO)
• National Institutes of Health (NIH)
• Centers for Medicare & Medicaid Services (CMS)
• National Health Service (NHS) Digital

Trade Publications

• MedTech Dive
• Becker’s Hospital Review
• Endoscopy Campus
• Medical Device Network
• Fierce Biotech
• Diagnostics World

Academic Journals

• Gastrointestinal Endoscopy Journal
• Surgical Endoscopy Journal
• Journal of Bronchology & Interventional Pulmonology
• World Journal of Gastroenterology
• Endoscopy International Open
• The Lancet Gastroenterology & Hepatology

Reputable Newspapers

• The New York Times – Health Section
• The Guardian – Healthcare Coverage
• The Washington Post – Health and Science
• Financial Times – Healthcare and Life Sciences
• The Wall Street Journal – Health Industry
• BBC News – Health

Industry Associations

• American Society for Gastrointestinal Endoscopy (ASGE)
• European Society of Gastrointestinal Endoscopy (ESGE)
• Society of Thoracic Surgeons (STS)
• American Gastroenterological Association (AGA)
• British Thoracic Society (BTS)
• Asia Pacific Society for Digestive Endoscopy (APSDE)

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years